Metabolix Announces Commencement of Public Offering of 4.75M Shares

Metabolix, Inc. MBLX today announced that it has commenced a public offering of shares of its common stock pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission. J.P. Morgan Securities LLC will serve as the sole book-running manager and Stifel Nicolaus Weisel will serve as the co-manager for this offering. The Company expects to offer 4.75 million newly issued shares. The underwriters also have the option to purchase up to an additional 15% percent of the offered amount of common stock from the Company at the public offering price, less underwriting discounts and commissions, within 30 days, to cover over-allotments, if any.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsOfferingsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!